Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapy.


Journal

Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 01 2019
revised: 19 02 2019
accepted: 08 03 2019
pubmed: 9 4 2019
medline: 18 4 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

Achalasia diagnosis requires elevated integrated relaxation pressure (IRP; manometric marker of lower esophageal sphincter [LES] relaxation). Yet, some patients exhibit clinical features of achalasia despite normal IRP and have LES dysfunction demonstrable by other means. We hypothesized these patients to exhibit equivalent therapeutic response compared to standard achalasia patients. Symptomatic achalasia-like cases, despite normal IRP, displayed evidence of impaired LES relaxation using rapid drink challenge (RDC), solid swallows during high-resolution manometry, and/or barium esophagogram; were treated with achalasia therapies and compared to standard achalasia patients with raised IRP. Outcomes included equivalence for short- and long-term symptom response and stasis on barium esophagogram. Twenty-nine normal IRP achalasia cases (14 males, median age 50 year, median Eckardt 6, barium stasis 12 ± 7 cm) and 29 consecutive standard achalasia controls underwent therapy. Among cases, LES dysfunction was most often identified by RDC and/or barium esophagogram. Short-term symptomatic success was equivalent in cases vs controls (90% vs 93%; 95% CI for difference: -19% to 13%). Median short-term (1 vs 1; 95% CI for difference: 0-1) and long-term Eckardt scores (2 vs 1; 95% CI for difference: 0-2) were similar in cases and controls, respectively. Adequate clearance was observed in 67% of cases vs 81% of controls on post-therapy esophagogram. We described a subset of achalasia patients with normal IRP, but impaired LES relaxation identifiable only on additional provocative tests. These patients benefited from treatment, suggesting that such tests should be performed to increase the number of clinically relevant diagnoses.

Sections du résumé

BACKGROUND
Achalasia diagnosis requires elevated integrated relaxation pressure (IRP; manometric marker of lower esophageal sphincter [LES] relaxation). Yet, some patients exhibit clinical features of achalasia despite normal IRP and have LES dysfunction demonstrable by other means. We hypothesized these patients to exhibit equivalent therapeutic response compared to standard achalasia patients.
METHODS
Symptomatic achalasia-like cases, despite normal IRP, displayed evidence of impaired LES relaxation using rapid drink challenge (RDC), solid swallows during high-resolution manometry, and/or barium esophagogram; were treated with achalasia therapies and compared to standard achalasia patients with raised IRP. Outcomes included equivalence for short- and long-term symptom response and stasis on barium esophagogram.
KEY RESULTS
Twenty-nine normal IRP achalasia cases (14 males, median age 50 year, median Eckardt 6, barium stasis 12 ± 7 cm) and 29 consecutive standard achalasia controls underwent therapy. Among cases, LES dysfunction was most often identified by RDC and/or barium esophagogram. Short-term symptomatic success was equivalent in cases vs controls (90% vs 93%; 95% CI for difference: -19% to 13%). Median short-term (1 vs 1; 95% CI for difference: 0-1) and long-term Eckardt scores (2 vs 1; 95% CI for difference: 0-2) were similar in cases and controls, respectively. Adequate clearance was observed in 67% of cases vs 81% of controls on post-therapy esophagogram.
CONCLUSIONS AND INFERENCES
We described a subset of achalasia patients with normal IRP, but impaired LES relaxation identifiable only on additional provocative tests. These patients benefited from treatment, suggesting that such tests should be performed to increase the number of clinically relevant diagnoses.

Identifiants

pubmed: 30957312
doi: 10.1111/nmo.13586
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13586

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Santosh Sanagapalli (S)

GI Physiology Unit, University College London Hospital, London, UK.
Department of Gastroenterology, St. Vincent's Hospital Sydney, Darlinghurst, Australia.

Sabine Roman (S)

Hôpital Edouard Herriot, Lyon, France.

Audrey Hastier (A)

Hôpital Edouard Herriot, Lyon, France.

Rupert W Leong (RW)

Gastroenterology & Liver Services, Concord Repatriation General Hospital, Sydney, Australia.

Kalp Patel (K)

GI Physiology Unit, University College London Hospital, London, UK.

Amanda Raeburn (A)

GI Physiology Unit, University College London Hospital, London, UK.

Matthew Banks (M)

GI Physiology Unit, University College London Hospital, London, UK.

Rehan Haidry (R)

GI Physiology Unit, University College London Hospital, London, UK.

Laurence Lovat (L)

GI Physiology Unit, University College London Hospital, London, UK.

David Graham (D)

GI Physiology Unit, University College London Hospital, London, UK.

Sarmed S Sami (SS)

GI Physiology Unit, University College London Hospital, London, UK.

Rami Sweis (R)

GI Physiology Unit, University College London Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH